A multicenter, open-label, phase 2 study of S-588410 as maintenance monotherapy after first-line platinum-containing chemotherapy in patients with advanced and/or metastatic bladder cancer
Phase of Trial: Phase II
Latest Information Update: 15 Apr 2019
Price : $35 *
At a glance
- Drugs Asudemotide (Primary)
- Indications Bladder cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Shionogi
- 11 Apr 2019 Status changed from active, no longer recruiting to completed.
- 03 Mar 2019 This has been completed in UK, according to European Clinical Trials Database.
- 09 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by UMIN record.